Literature DB >> 1337961

Effects of cyclosporine on tubular acidification function in patients with idiopathic uveitis.

S Aguilera1, G Deray, H Desjobert, M Benhmida, P Le Hoang, C Jacobs.   

Abstract

Renal tubular acidification function was studied in 12 patients treated with cyclosporine (Cy) for idiopathic uveitis (IU) and in 5 patients with IU not treated with Cy. After intravenous bicarbonate loading fractional bicarbonate excretion was similar in both groups indicating normal proximal tubular acidification function. Plasma renin activity, plasma aldosterone and transtubular potassium gradient were similar in both groups. Distal hydrogen ion secretion evaluated by the ability to increase urine-blood (U-B) pCO2 in a highly alkaline urine was impaired in Cy-treated patients (31.8 +/- 3.2 mm Hg) as compared to controls (47.9 +/- 0.5 mm Hg) (p < 0.005). We conclude that Cy therapy is associated with a distal acidification defect with a low U-B pCO2 gradient during sodium bicarbonate loading. Because none of our Cy-treated patients spontaneously developed over metabolic acidosis one could classify them as having an incomplete form of distal tubular acidosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337961     DOI: 10.1159/000168493

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  2 in total

1.  Isolated hyperkalemia associated with cyclosporine administration in allogeneic stem cell transplantation for renal cell carcinoma.

Authors:  Akiyoshi Takami; Hidesaku Asakura; Hiroyuki Takamatsu; Hirohito Yamazaki; Masahisa Arahata; Tomoe Hayashi; Masami Shibayama; Michiko Orito; Tomotaka Yoshida; Mikio Namiki; Shinji Nakao
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

2.  Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Authors:  Ludwig Stapenhorst; Robert Sassen; Bodo Beck; Norbert Laube; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.